RESUMO
The Breast Cancer Resistance Protein (BCRP/ABCG2) is an ATP-binding cassette efflux transporter that is expressed in the apical membrane of cells from relevant tissues involved in drug pharmacokinetics such as liver, intestine, kidney, testis, brain and mammary gland, among others. Tolfenamic acid is an anti-inflammatory drug used as an analgesic and antipyretic in humans and animals. Recently, tolfenamic acid has been repurposed as an antitumoral drug and for use in chronic human diseases such as Alzheimer. The aim of this work was to study whether tolfenamic acid is an in vitro Abcg2 substrate, and to investigate the potential role of Abcg2 in plasma exposure, secretion into milk and tissue accumulation of this drug. Using in vitro transepithelial assays with cells transduced with Abcg2, we showed that tolfenamic acid is an in vitro substrate of Abcg2. The in vivo effect of this transporter was tested using wild-type and Abcg2-/- mice, showing that after oral and intravenous administration of tolfenamic acid, its area under the plasma concentration-time curve in Abcg2-/- mice was between 1.7 and 1.8-fold higher compared to wild-type mice. Abcg2-/- mice also showed higher liver and testis accumulation of tolfenamic acid after intravenous administration. In this study, we demonstrate that tolfenamic acid is transported in vitro by Abcg2 and that its plasma levels as well as its tissue distribution are affected by Abcg2, with potential pharmacological and toxicological consequences.
Assuntos
Membro 2 da Subfamília G de Transportadores de Cassetes de Ligação de ATP/metabolismo , Vacinas Bacterianas/sangue , Vacinas Bacterianas/farmacocinética , ortoaminobenzoatos/sangue , ortoaminobenzoatos/farmacocinética , Animais , Vacinas Bacterianas/farmacologia , Transporte Biológico , Camundongos , Distribuição Tecidual , ortoaminobenzoatos/farmacologiaRESUMO
The mucosal surfaces of fish allow for the introduction of foreign substances, including antigens, from the surrounding environment. In this study, uptake of Vibrio anguillarum J-O-3 serotype bacterin by Japanese flounder, and the subsequent immune responses were investigated. Immunohistochemistry revealed that the bacterin was taken up through the epithelial cells of gills. The transcription levels of inflammatory cytokines such as interleukin (IL)-1ß, IL-6 and tumor necrosis factor α were significantly up-regulated in the gills at 3 days following exposure to the bacterin. There was also a corresponding increase in IL-8 receptor, CD4-1, CD4-2 and CD8α transcript levels in the gills. Our findings suggest that the gills play a major role in the uptake of V. anguillarum bacterin and induction of inflammation, which results in an activation of the adaptive immune response in teleost fish.
Assuntos
Vacinas Bacterianas/farmacologia , Linguado/imunologia , Regulação da Expressão Gênica/imunologia , Vibrio/imunologia , Animais , Anticorpos Antibacterianos/sangue , Aquicultura/métodos , Vacinas Bacterianas/administração & dosagem , Vacinas Bacterianas/farmacocinética , Primers do DNA/genética , Ensaio de Imunoadsorção Enzimática/veterinária , Linguado/microbiologia , Regulação da Expressão Gênica/efeitos dos fármacos , Brânquias/metabolismo , Imuno-Histoquímica/veterinária , Reação em Cadeia da Polimerase Via Transcriptase Reversa/veterináriaRESUMO
We recently demonstrated by in vitro experiments that PLGA (poly D, L-lactide-co-glycolide) potentiates T helper 1 (Th1) immune responses induced by a peptide derived from the recombinant major outer membrane protein (rMOMP) of Chlamydia trachomatis, and may be a promising vaccine delivery system. Herein we evaluated the immune-potentiating potential of PLGA by encapsulating the full-length rMOMP (PLGA-rMOMP), characterizing it in vitro, and investigating its immunogenicity in vivo. Our hypothesis was that PLGA-rMOMP triggers Th1 immune responses in mice, which are desirable prerequisites for a C. trachomatis candidate nanovaccine. Physical-structural characterizations of PLGA-rMOMP revealed its size (approximately 272 nm), zeta potential (-14.30 mV), apparent spherical smooth morphology, and continuous slow release pattern. PLGA potentiated the ability of encapsulated rMOMP to trigger production of cytokines and chemokines by mouse J774 macrophages. Flow cytometric analyses revealed that spleen cells from BALB/c mice immunized with PLGA-rMOMP had elevated numbers of CD4+ and CD8+ T cell subsets, and secreted more rMOMP-specific interferon-gamma (Th1) and interleukin (IL)-12p40 (Th1/Th17) than IL-4 and IL-10 (Th2) cytokines. PLGA-rMOMP-immunized mice produced higher serum immunoglobulin (Ig)G and IgG2a (Th1) than IgG1 (Th2) rMOMP-specific antibodies. Notably, sera from PLGA-rMOMP-immunized mice had a 64-fold higher Th1 than Th2 antibody titer, whereas mice immunized with rMOMP in Freund's adjuvant had only a four-fold higher Th1 than Th2 antibody titer, suggesting primarily induction of a Th1 antibody response in PLGA-rMOMP-immunized mice. Our data underscore PLGA as an effective delivery system for a C. trachomatis vaccine. The capacity of PLGA-rMOMP to trigger primarily Th1 immune responses in mice promotes it as a highly desirable candidate nanovaccine against C. trachomatis.
Assuntos
Vacinas Bacterianas/imunologia , Chlamydia trachomatis/imunologia , Nanopartículas/química , Porinas/imunologia , Vacinas de Subunidades Antigênicas/imunologia , Animais , Anticorpos Antibacterianos/sangue , Vacinas Bacterianas/química , Vacinas Bacterianas/farmacocinética , Linhagem Celular , Quimiocinas/análise , Quimiocinas/metabolismo , Citocinas/análise , Citocinas/metabolismo , Feminino , Citometria de Fluxo , Ácido Láctico/química , Macrófagos , Camundongos , Camundongos Endogâmicos BALB C , Ácido Poliglicólico/química , Copolímero de Ácido Poliláctico e Ácido Poliglicólico , Porinas/química , Porinas/farmacocinética , Proteínas Recombinantes/química , Proteínas Recombinantes/imunologia , Proteínas Recombinantes/farmacocinética , Células Th1 , Vacinas de Subunidades Antigênicas/química , Vacinas de Subunidades Antigênicas/farmacocinéticaRESUMO
Dendritic cells (DCs) are key regulators of adaptive T-cell responses. By capturing exogenous antigens and presenting antigen-derived peptides via major histocompatibility complex molecules to naïve T cells, DCs induce antigen-specific immune responses in vivo. In order to induce effective host immune responses, active delivery of exogenous antigens to DCs is considered important for future vaccine development. We recently generated bionanocapsules (BNCs) consisting of hepatitis B virus surface antigens that mediate stringent in vivo cell targeting and efficient endosomal escape, and after the fusion with liposomes (LP) containing therapeutic materials, the BNC-LP complexes deliver them to human liver-derived tissues in vivo. BNCs were further modified to present the immunoglobulin G (IgG) Fc-interacting domain (Z domain) derived from Staphylococcus aureus protein A in tandem. When mixed with IgGs, modified BNCs (ZZ-BNCs) displayed the IgG Fv regions outwardly for efficient binding to antigens in an oriented-immobilization manner. Due to the affinity of the displayed IgGs, the IgG-ZZ-BNC complexes accumulated in specific cells and tissues in vitro and in vivo. After mixing ZZ-BNCs with antibodies against DCs, we used immunocytochemistry to examine which antibodies delivered ZZ-BNCs to mouse splenic DCs following intravenous injection of the ZZ-BNCs. ZZ-BNCs displaying anti-CD11c monoclonal antibodies (α-CD11c-ZZ-BNCs) were found to accumulate with approximately 62% of splenic DCs, and reside within some of them. After the fusion with liposomes containing antigens, the α-CD11c-ZZ-BNCs could elicit the respective antibodies more efficiently than other nontargeting control vaccines, suggesting that this DC-specific nanocarrier is promising for future vaccines.
Assuntos
Células Dendríticas/metabolismo , Antígenos de Superfície da Hepatite B/metabolismo , Nanocápsulas/química , Proteínas Recombinantes de Fusão/metabolismo , Proteínas do Envelope Viral/metabolismo , Animais , Anticorpos Monoclonais/metabolismo , Antígenos Virais/imunologia , Vacinas Bacterianas/química , Vacinas Bacterianas/imunologia , Vacinas Bacterianas/metabolismo , Vacinas Bacterianas/farmacocinética , Vírus da Encefalite Japonesa (Espécie)/imunologia , Feminino , Antígenos de Superfície da Hepatite B/química , Lipossomos/química , Lipossomos/imunologia , Lipossomos/metabolismo , Lipossomos/farmacocinética , Camundongos , Camundongos Endogâmicos BALB C , Nanocápsulas/administração & dosagem , Proteínas Recombinantes de Fusão/química , Proteínas Recombinantes de Fusão/imunologia , Proteínas Recombinantes de Fusão/farmacocinética , Baço/citologia , Proteína Estafilocócica A/química , Proteína Estafilocócica A/genética , Proteína Estafilocócica A/metabolismo , Distribuição Tecidual , Proteínas do Envelope Viral/química , Proteínas Virais/imunologiaRESUMO
This study was focused on the utilization of a recombinant expression system to produce a unique modified subunit vaccine possessing a self-contained delivery system which could potentially improve the uptake and delivery of vaccine products as well their immunogenic potential. For this purpose the A-layer protein (At-R) associated with the fish pathogen atypical Aeromonas salmonicida was cloned and modified by the genetic fusion of the protein transduction domain (MTS) derived from Kaposi fibroblast growth factor (At-MTS). The potential for these proteins to be employed as antigens for oral immunization of goldfish was examined by encapsulation of At-R, At-MTS and the control, BSA, into biodegradable alginate gel macrospheres which were fed to goldfish in place of standard pellet fish feed. The bead physical properties were modified only in the presence of At-R and the temporal release of proteins was significantly less when At-MTS was employed. Western blot analysis of serum samples collected from fish following intubation with the recombinant proteins determined that the rate of protein uptake from the digestive tract into the blood system improved considerably when MTS was fused to At-R. Experimental fish were fed one of three protein-alginate formulae on a schedule of 3 days/week or 5 days/month for a period of 2 months. After 1 month, animals fed on the 5-day protocol demonstrated increased serum antibody titers while following an additional month of feeding this level decreased and titers were found to be higher in fish maintained on the 3-day regime. Fish fed At-MTS maintained the highest titer at the end of 2-month period. To determine whether the diminished antibody titers were a result of oral tolerance fish were injected intraperitoneally with the At-R antigen. Only experimental groups which had been fed At-R or At-MTS demonstrated increased antibody titers which paralleled a typical secondary humoral response. In spite of the presence of an increased titer to A-protein, vaccinated fish did not demonstrate resistance to infection with atypical A. salmonicida.
Assuntos
Aeromonas salmonicida/imunologia , Vacinas Bacterianas/imunologia , Fatores de Crescimento de Fibroblastos/imunologia , Doenças dos Peixes/prevenção & controle , Carpa Dourada/imunologia , Infecções por Bactérias Gram-Negativas/veterinária , Proteínas Proto-Oncogênicas/imunologia , Administração Oral , Alginatos/administração & dosagem , Animais , Anticorpos Antibacterianos/sangue , Proteínas de Bactérias/administração & dosagem , Proteínas de Bactérias/genética , Proteínas de Bactérias/imunologia , Vacinas Bacterianas/administração & dosagem , Vacinas Bacterianas/genética , Vacinas Bacterianas/farmacocinética , Fator 4 de Crescimento de Fibroblastos , Ácido Glucurônico/administração & dosagem , Ácido Glucurônico/imunologia , Infecções por Bactérias Gram-Negativas/prevenção & controle , Ácidos Hexurônicos/administração & dosagem , Ácidos Hexurônicos/imunologia , Imunoglobulina G/sangue , Absorção Intestinal , Israel , Cinética , Microesferas , Estrutura Terciária de Proteína , Vacinação/métodos , Vacinação/veterinária , Vacinas Sintéticas/administração & dosagem , Vacinas Sintéticas/genética , Vacinas Sintéticas/imunologiaRESUMO
Chitosan microspheres were prepared by ionic gelation process with sodium sulfate for nasal vaccine delivery. Bordetella Bronchiseptica Dermonecrotoxin (BBD) as a major virulence factor of a causative agent of atrophic rhinitis (AR) was loaded to the chitosan microspheres for vaccination. Morphology of BBD-loaded chitosan microspheres was observed as spherical shapes. The average particle sizes of the BBD-loaded chitosan microspheres were about 2.69 microm. More BBD was released with an increase of molecular weight of chitosan and with an increase of medium pH in vitro due to weaker intermolecular interaction between chitosan and BBD. Tumor necrosis factor-alpha (TNFalpha) and nitric oxide (NO) from RAW264.7 cells stimulated with BBD-loaded chitosan microspheres were gradually secreted, suggesting that released BBD from chitosan microspheres had immune stimulating activity of AR vaccine.
Assuntos
Toxinas Bacterianas/farmacocinética , Vacinas Bacterianas/farmacocinética , Bordetella bronchiseptica/metabolismo , Quitina/análogos & derivados , Quitina/farmacocinética , Microesferas , Transglutaminases/farmacocinética , Fatores de Virulência de Bordetella/farmacocinética , Animais , Bordetella bronchiseptica/efeitos dos fármacos , Linhagem Celular , Quitina/ultraestrutura , Quitosana , Preparações de Ação Retardada/farmacocinética , Luz , Camundongos , Microscopia Eletrônica de Varredura , Espalhamento de Radiação , Suínos , Transglutaminases/ultraestruturaRESUMO
Se evaluó la cinética de la respuesta de anticuerpos bactericidas frente a la cepa vacunal Cu85/83 (B:4P1.15) y de la IgG específica contra proteínas vacunales (PV) en 220 individuos vacunados con VA-MENGOC-BC, vacuna cubana contra la Neisseria meningitidis serogrupo B y C. Se realizó un análisis multivariado y los mayores incrementos de IgG anti-PV y de la actividad bactericida sérica (ABs) se observaron después de la segunda dosis vacunal, lo que sugiere la existencia de memoria inmunológica dependiente de células B como mecanismo protector